Peripheral Pharmacovigilance Centre Erode

30/06/2025

NSQ Drug:

If it is sold, or offered or exhibited for sale, under a name which belongs to another drug.
If it is an imitation of, or is a substitute for, another drug or resembles another drug in a manner likely to deceive, or bears upon it or upon its label or container the name of another drug, unless it is plainly and conspicuously marked so as to reveal its true character and its lack of identity with such other drug.
If the label or container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist.
If it has been substituted wholly or in part by any other drug or substance.
If it purports to be the product of a manufacturer of whom it is not truly a product.

19/06/2025

Misbranded Drug:

If it is so coloured, coated, powered or polished that damage is concealed, or if it is made to appear of better or greater therapeutic value than it really is.
If it is not labelled in the prescribed manner.
If its label or container or anything accompanying the drug bears any statement, design or device which makes any false claim for the drug or which is false or misleading in any particular.

Adulterated Drug:

If it consists, in whole or in part, of any filthy, putrid or decomposed substance.
If it has been prepared, packed or stored under insanitary conditions whereby it may have been contaminated with filth or whereby it may have been rendered injurious to health.
If its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health.
If it bears or contains, for purposes of colouring only, a colour other than one which is prescribed.
If it contains any harmful or toxic substance which may render it injurious to health.
If any substance has been mixed therewith so as to reduce its quality or strength.

04/12/2024

https://youtu.be/tjmwMVWRHdg?feature=shared

Pharmacovigilance Awareness Week - Short Video Competition - Dr. J Abinash and Team - Excel Siddha Clg

03/12/2024

Hierarchy of Pharmacovigilance:

The nationwide programme under central sector scheme funded by Ministry of AYUSH, New Delhi for ASU & H drugs to establish and manage a data base of Adverse Drug Reactions (ADR) for developing system wise database of adverse drug reactions and evolving evidence based recommendations towards clinical safety of ASU & H Drugs. Besides this the program also undertake surveillance of objectionable or misleading advertisements.

National Pharmacovigilance Coordination Centre (NPvCC):

It is a tertiary pharmacovigilance centre, acting as the National Centre in the administrative structure of the program.
Ministry of AYUSH, New Delhi has designated All India Institute of Ayurveda (AIIA), New Delhi as National Pharmacovigilance Coordination Centre (NPvCC).

Intermediary Pharmacovigilance Centres (IPvCs):

Secondary pharmacovigilance centres, acting as second level centres in the administrative structure of the program.
Five National Institutes (National Institute of Ayurveda, Jaipur; Institute of Teaching and Research in Ayurveda, Jamnagar; National Institute of Siddha, Chennai; National Institute of Unani Medicine, Bengaluru; and National Institute of Homoeopathy, Kolkata) are designated as Intermediary Pharmacovigilance Centres.

Peripheral Pharmacovigilance Centres (PPvCs):

Primary pharmacovigilance centres.
They are relatively smaller ASU & H colleges or institutions including.
These are the first contact ADR data collection units.
They would be identified and coordinated by IPvCs in consultation with NPvCC.

23/09/2024

*Announcement: Infographic Competition Submission Date Extended*

We are excited to see the enthusiasm for the Infographic Competition! Due to time constraints and increased interest from participants, we are postponing the last date from *23rd September 2024* to *30th September 2024*. This extension will allow more individuals to join and showcase their creativity.

An *Infograph* (or infographic) is a visual representation of information, data, or knowledge designed to present complex concepts quickly and clearly. It combines text, graphics, and data visualizations (such as charts, graphs, and icons) to communicate information efficiently, making it more engaging and easier to understand.

# # # Key Components of an Infographic:
1. *Title*: A clear and concise headline that introduces the topic.
2. *Graphics*: Icons, illustrations, and images that represent key ideas visually.
3. *Text*: Short and focused text sections that explain the visual elements.
4. *Data Visualization*: Charts, graphs, and tables to represent numerical data.
5. *Structure*: A logical flow or hierarchy that guides the viewer through the information.

# # # Steps to Create an Infographic:

1. *Choose a Topic*
- Pick a clear, focused subject you want to communicate (e.g., “Pharmacovigilance in AYUSH”).

2. *Gather Data and Information*
- Collect relevant data, facts, and figures that will support your main message.
- Make sure your sources are credible.

3. *Decide on the Structure*
- Plan the flow of information, breaking it down into sections like introduction, key points, and conclusion.

4. *Choose the Right Design Tool*
- Use online tools like *Canva, **Piktochart, or **Adobe Spark* for beginners, or more advanced software like *Adobe Illustrator* if you have design experience.

5. *Create a Layout*
- Arrange your content in a balanced way, keeping it visually appealing with enough space between elements.
- Ensure the design follows a logical path so viewers can easily follow along.

6. *Use Visuals*
- Incorporate icons, graphs, or images that support and clarify your message.
- Use contrasting colors to highlight important information and maintain readability.

7. *Keep it Simple*
- Focus on key points, avoiding overcrowding with too much text or complex data.
- Use a consistent font style, size, and color scheme to maintain visual harmony.

8. *Review and Edit*
- Proofread the text for errors and ensure all data is accurate.
- Check the infographic’s readability and make sure all visual elements are aligned properly.

Thank you for your understanding and we look forward to your amazing submissions! Below mentioned picture is an example of an infographic and for further ideas watch the below youtube link

https://youtu.be/av4QX41Mtf0?feature=shared

🎉 Exciting prizes await the winners!

Let's work together to ensure the safety of ourselves! 💊✨

Registration Link: https://forms.gle/LKGy895uRKeCdcy59

📌 Submission Guidelines:
- Format: Pdf, Jpg or Jpeg
- Deadline: September 30th, 2024
- Submit your entries to: [ppvcayusherode@gmail.com]

For more details, feel free to contact :
Dr. G. Pratheep BSMS
Junior Research Fellow
PPvC Erode (006)
WhatsApp - (9360121130)

With Regards,
Dr. D. Venkatachalam MD(S), PGDPHM
Coordinator,
PPvC Erode (006),
Tamilnadu.

31/08/2024

*📢 Infographic Competition Alert!* 🏆

Join us in celebrating *National Pharmacovigilance Week* from *September 17th to 23rd, 2024*!

The *Peripheral Pharmacovigilance Centre, Erode (006), Tamilnadu* is excited to announce an *Infographic Competition*. This is your chance to showcase your creativity and contribute to promoting drug safety awareness.

📌 *Submission Guidelines:*
- Format: Pdf, Jpg or Jpeg
- Deadline: September 23rd, 2024
- Submit your entries to: [ppvcayusherode@gmail.com]

🎉 *Exciting prizes await the winners!*

For more details, feel free to contact us on WhatsApp (9360121130)

Let's work together to ensure safety of ourselves! 💊✨

Registration Link: https://forms.gle/LKGy895uRKeCdcy59

18/05/2024

Nee of the hour - Pharmacovigilance:

Pharmacovigilance (PV) plays a key role in the healthcare system through assessment, monitoring and discovery of interactions amongst drugs and their effects in humans.

Pharmaceutical medicines are designed to cure, prevent or treat diseases; however, there are also risks particularly adverse drug reactions (ADRs) can cause serious harm to patients. Thus, for safety medication ADRs monitoring required for each medicine throughout its life cycle, during development of drugs such as pre-marketing including early stages of drug design, clinical trials, and post-marketing surveillance.

PV is concerns with the detection, assessment, understanding and prevention of ADRs. Pharmacogenetics and pharmacogenomics are an indispensable part of the clinical research. Variation in the human genome is a cause of variable response to drugs and susceptibility to diseases are determined, which is important for early drug discovery to PV.

Moreover, PV has traditionally involved in mining spontaneous reports submitted to national surveillance systems. The research focus is shifting toward the use of data generated from platforms outside the conventional framework such as electronic medical records, biomedical literature, and patient-reported data in health forums.

The emerging trend in PV is to link premarketing data with human safety information observed in the post-marketing phase. The PV system team obtains valuable additional information, building up the scientific data contained in the original report and making it more informative. This necessitates an utmost requirement for effective regulations of the drug approval process and conscious pre and post approval vigilance of the undesired effects, especially in India.

Adverse events reported by PV system potentially benefit to the community due to their proximity to both population and public health practitioners, in terms of language and knowledge, enables easy contact with reporters by electronically. Hence, PV helps to the patients get well and to manage optimally or ideally, avoid illness is a collective responsibility of industry, drug regulators, clinicians and other healthcare professionals to enhance their contribution to public health.

25/11/2023

https://youtu.be/_i1glF3-1kY?si=kDIjq2sMV67NRROA

Peripheral Pharmacovigilance Week - Short Video Competition - Dr.Arun Prasath and Team - Velumaiyilu Siddha Medical College and Hospital

06/11/2023

The Central Drugs Standard Control Organisation(CDSCO):

It comes under Directorate of General of Health Services, Ministry of Health & Family Welfare and Government of India is the National Regulatory Authority (NRA) of India. It's headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002 and also has six zonal offices,four sub zonal offices,thirteen Port offices and seven laboratories spread across the country.

The Drugs & Cosmetics Act,1940 and rules 1945 have entrusted various responsibilities to central & state regulators for regulation of drugs & cosmetics.It envisages uniform implementation of the provisions of the Act and Rules made there under for ensuring the safety, rights and well being of the patients by regulating the drugs and cosmetics.

CDSCO is constantly thriving upon to bring out transparency, accountability and uniformity in its services in order to ensure safety, efficacy and quality of the medical product manufactured, imported and distributed in the country.

Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice with a view of bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.

Further CDSCO along with state regulators, is jointly responsible for grant of licenses of certain specialized categories of critical Drugs such as blood and blood products, I. V. Fluids and Vaccine.

16/10/2023

https://youtu.be/F2zV3nAaD8o?si=sqM6plx9Si-gQ_M7

This video refers to the problems faced by common people during self medication and the importance of consulting a doctor at the right time to avoid any emer...

13/10/2023

Short Video Competition Prize List:

We are happy and honoured to announce that numerous enthusiastic contestants have participated in the Short Video competition held by our Peripheral Pharmacovigilance Centre Erode (006), for the National Pharmacovigilance Week (17th - 23rd) September 2023. A panel of experts have gone through the videos and finalized the results depending upon the content, management of resources, time management and efforts taken..For us all the participants have done a great job and deserve to be winners..Here is the final list of winners selected by our panelists and they will be honoured in the upcoming event.

First Place - A.Sweatha & Team (Excel Siddha College)

First Place - G.Arun Prasath & Team (Velumaiyulu Siddha College)

Second Place - Kehren R Rayma (Velumaiyulu Siddha College)

Second Place - Mennsruthhi Sivakarthikeyan & Team (Excel Siddha College)

Third Place - J.Abinash & Team (Excel Siddha College)

Third Place - S.Nila Fathima & Team (Excel Siddha College)

Consolation Prizes :

Dr.D.Sivasankari & Team (GSMC Chennai)

Dr.R.S.Parvathy (Private Practitioner)

You can also view this in our official website - www.ppvcayusherode.com

https://www.ppvcayusherode.com/post/short-video-competition-prize-list

19/09/2023

As per the request received from aspiring participants, the last date for submission of short videos has been extended till 23rd September (Saturday Eve 5 pm) So kindly use this opportunity to enhance your video and present your best..A hearty wishes to every participant and special prizes are waiting for you.. Those who have not started yet try to start now coz there are only 3 more days to go.. Kindly fill in the form below and send a screenshot along with the video.

https://forms.gle/dfaUy9WJPHN1rvfx6

Or

Kindly upload the video along with the form

https://forms.gle/b74FPPJReEaSPSZE9